Dapagliflozin
NDC 70748-106, Dapagliflozin, tablet, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 70748-106
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211531
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70748-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPAGLIFLOZIN10 mg/1
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70748-106-06 | 70748010606 | 30 TABLET in 1 BOTTLE (70748-106-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/08baca21-e39e-4e61-961f-d89432fe8007NADAC price for package 70748010606
GET /v1/drugs/nadac/70748010606
Use it
Look up 70748-106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70748-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70748-106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.